Neoolife is pioneering and leading the field of tissue-engineered Biomimetic Heart Valves (BMHV) with polymeric scaffolds enabling endogenous in-situ tissue regeneration. Neoolife will replace mechanical and animal-derived tissue valves with tissue-engineered Biomimetic Heart Valves designed to have an extended duration without the need for blood-thinning drugs. Neoolife tissue-engineered Biomimetic Heart Valves provide a technological solution to the clinicians’ demands of enlarging the pool of patients that can benefit from Transcatheter Heart Valve Therapy.
Location: United States, Pennsylvania, Pittsburgh
Employees: 1-10
Founded date: 2020